BioCentury | Sep 26, 2011
Finance

SQI looks south

...At least $10.9 million was invested in Scienion by investors including Peppermint Venture Capital (27.6%); IBB Beteiligungsgesellschaft...
BioCentury | Apr 18, 2011
Financial News

OctreoPharm completes venture financing

...Germany Business: Diagnostic Date completed: 3/18/11 Type: Venture financing Raised: €5 million ($7 million) Investors: IBB Beteiligungsgesellschaft...
BioCentury | May 24, 2010
Financial News

caprotec completes venture financing

...Supply/Service Date completed: 5/13/10 Type: Venture financing Raised: €4 million ($4.9 million) Investors: Creathor Venture; IBB Beteiligungsgesellschaft...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Jerini Germany $59.8 HealthCap; TVM Techno Venture Management; 3i; Sanders Morris Harris Group; PolyTechnos Venture-Partners; IBB Beteiligungsgesellschaft...
BioCentury | Feb 21, 2005
Finance

Ebb & Flow

The last time FibroGen raised money was a $56.5 million series E round in September 2000 - shortly after the genomics bubble burst. That left the prelinical company with a hefty post-money valuation around $280 million....
BioCentury | Feb 14, 2005
Financial News

Jerini raises EUR 15.5M

Jerini (Berlin, Germany) raised EUR 15.5 million ($19.9 million) in a second closing of its June 2004 series B round, bringing to EUR 46.5 million the total raised in the round. Investors in the second...
BioCentury | Sep 13, 2004
Emerging Company Profile

Corporate Profile

...Kiel Employees: 26 Funds raised: E6 million ($7 million) Investors: 3i Group; Peppermint Financial Partners; IBB Beteiligungsgesellschaft...
BioCentury | Jun 14, 2004
Finance

Ebb & Flow Focus

More than three years after the last biotech IPO in Germany, there's a glimmer of light at the end of the tunnel, as companies are starting to talk about the possibility of going public in...
BioCentury | Jun 9, 2004
Top Story

Jerini raises EUR 31 million

Cancer, autoimmune and inflammation company Jerini (Berlin, Germany) raised EUR 31 million ($38.1 million) in a series B round co-led by HealthCap; TVM Techno Venture Management; and 3i. Other investors included Sanders Morris Harris; PolyTechnos...
BioCentury | Feb 19, 2002
Emerging Company Profile

Corporate Profile

...Number of employees: 80 Funds raised: E24.6 million ($21.2 million) Investors: bmp Life Science AG; IBB Beteiligungsgesellschaft...
Items per page:
1 - 10 of 10
BioCentury | Sep 26, 2011
Finance

SQI looks south

...At least $10.9 million was invested in Scienion by investors including Peppermint Venture Capital (27.6%); IBB Beteiligungsgesellschaft...
BioCentury | Apr 18, 2011
Financial News

OctreoPharm completes venture financing

...Germany Business: Diagnostic Date completed: 3/18/11 Type: Venture financing Raised: €5 million ($7 million) Investors: IBB Beteiligungsgesellschaft...
BioCentury | May 24, 2010
Financial News

caprotec completes venture financing

...Supply/Service Date completed: 5/13/10 Type: Venture financing Raised: €4 million ($4.9 million) Investors: Creathor Venture; IBB Beteiligungsgesellschaft...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Jerini Germany $59.8 HealthCap; TVM Techno Venture Management; 3i; Sanders Morris Harris Group; PolyTechnos Venture-Partners; IBB Beteiligungsgesellschaft...
BioCentury | Feb 21, 2005
Finance

Ebb & Flow

The last time FibroGen raised money was a $56.5 million series E round in September 2000 - shortly after the genomics bubble burst. That left the prelinical company with a hefty post-money valuation around $280 million....
BioCentury | Feb 14, 2005
Financial News

Jerini raises EUR 15.5M

Jerini (Berlin, Germany) raised EUR 15.5 million ($19.9 million) in a second closing of its June 2004 series B round, bringing to EUR 46.5 million the total raised in the round. Investors in the second...
BioCentury | Sep 13, 2004
Emerging Company Profile

Corporate Profile

...Kiel Employees: 26 Funds raised: E6 million ($7 million) Investors: 3i Group; Peppermint Financial Partners; IBB Beteiligungsgesellschaft...
BioCentury | Jun 14, 2004
Finance

Ebb & Flow Focus

More than three years after the last biotech IPO in Germany, there's a glimmer of light at the end of the tunnel, as companies are starting to talk about the possibility of going public in...
BioCentury | Jun 9, 2004
Top Story

Jerini raises EUR 31 million

Cancer, autoimmune and inflammation company Jerini (Berlin, Germany) raised EUR 31 million ($38.1 million) in a series B round co-led by HealthCap; TVM Techno Venture Management; and 3i. Other investors included Sanders Morris Harris; PolyTechnos...
BioCentury | Feb 19, 2002
Emerging Company Profile

Corporate Profile

...Number of employees: 80 Funds raised: E24.6 million ($21.2 million) Investors: bmp Life Science AG; IBB Beteiligungsgesellschaft...
Items per page:
1 - 10 of 10